Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: FDA Approves Braftovi
In today’s Pharmaceutical Executive Daily, the FDA approves Braftovi for mutant metastatic colorectal cancer, Novo Nordisk and GSK announce major dea…
4 months, 2 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk Announces Price Reductions for GLP-1 Products
In today’s Pharmaceutical Executive Daily, AbbVie invests $380 million to expand API manufacturing capacity while Bora Pharmaceuticals and GSK enter …
4 months, 2 weeks ago
Pharmaceutical Executive Daily: BioNTech Files Patent iInfringement Lawsuit Against Moderna
In today’s Pharmaceutical Executive Daily, BioNTech files a patent infringement lawsuit against Moderna, the Supreme Court rules against a large numb…
4 months, 3 weeks ago
Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals
In today’s Pharmaceutical Executive Daily, the FDA reportedly removes its two-study requirement for new drug approvals, Hims & Hers enters a $1 billi…
4 months, 3 weeks ago
Pharmaceutical Executive Daily: FDA Initiates Review of Moderna’s Seasonal Influenza Vaccine
In today’s Pharmaceutical Executive Daily, the FDA begins reviewing Moderna’s seasonal flu vaccine under a revised regulatory approach, Eli Lilly sig…
4 months, 3 weeks ago
Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro
In today’s Pharmaceutical Executive Daily, the FDA approves a monthly dosing schedule for Rybrevant Faspro, HHS Secretary Robert F. Kennedy Jr. revis…
4 months, 3 weeks ago
Pharmaceutical Executive Daily: Disc Medicine Receives CRL from FDA for Bitopertin
In today’s Pharmaceutical Executive Daily, the FDA issues a Complete Response Letter for Disc Medicine’s bitopertin in EPP, Edwards Lifesciences lift…
4 months, 3 weeks ago
Pharmaceutical Executive Daily: Eli Lilly's $1.5 Billion Stockpile of Orforglipron
In today’s Pharmaceutical Executive Daily, Eli Lilly builds a $1.5 billion stockpile of Orforglipron ahead of an FDA decision, PTC Therapeutics withd…
5 months ago
Pharmaceutical Executive Daily: FDA Issues Refusal-to-File Letter to Moderna
In today’s Pharmaceutical Executive Daily, the FDA issues a refusal-to-file letter to Moderna for its seasonal influenza vaccine as the company secur…
5 months ago
Pharmaceutical Executive Daily: Specialized Wealth Management for BioPharmaceutical Sales
In today’s Pharmaceutical Executive Daily, frontline biopharma sales professionals are increasingly turning to specialized wealth management advisory…
5 months ago